A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation.

PHASE4TerminatedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

January 31, 2007

Conditions
AnalgesiaSedation
Interventions
DRUG

Sufentanil

DRUG

Remifentanil

Trial Locations (10)

18057

GSK Clinical Trials Call Center, Rostock

19049

GSK Clinical Trials Call Center, Schwerin

24105

GSK Clinical Trials Call Center, Kiel

53105

GSK Clinical Trials Call Center, Bonn

66119

GSK Clinical Trials Call Center, Saarbrücken

66421

GSK Clinical Trials Call Center, Homburg/Saar

67063

GSK Clinical Trials Call Center, Ludwigshafen

69120

GSK Clinical Trials Call Center, Heidelberg

72076

GSK Clinical Trials Call Center, Tübingen

01067

GSK Clinical Trials Call Center, Dresden

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00421720 - A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation. | Biotech Hunter | Biotech Hunter